Grant: CIHR Fellowship
Direct Payment
$150,000.00
Revealing the Plasmodium falciparum virulence protein export system
EF 2010-11
Résumé
This project focuses on understanding a critical process employed by the parasite Plasmodium falciparum, the causative agent of Malaria, during infection of human red blood cells. Malaria is a widespread parasitic disease that infects up to 500 million people and causes 1 million deaths a year. Drug treatments against Malaria are at risk of losing effectiveness due to increasing parasite drug resistance; thus there is an urgent need to obtain a better understanding of the biology of this organism. Malaria parasites are capable of invading and reproducing in human red blood cells (RBCs) and the parasites have developed a sophisticated system that employs hundreds of parasite virulence proteins to alter the surface features of the RBCs. These alterations, mediated by an adhesion protein, cause the infected RBCs to obstruct capillaries in several organs such as the brain, kidney and placenta leading many of the fatal clinical symptoms of the disease. In recent years a virulence protein export system has been identified that provides the mechanisms to target and transport proteins from within the parasite, across the parasitophorous vacuole membrane (PVM), into the RBC cytoplasm. Virulence proteins destined for export have a particular amino acid sequence that is recognized and cleaved by a protease named plasmepsin-V (PM-V). Following this, the cleaved protein is ferried by an unknown mechanism to a proposed molecular transporter named PTEX that may allow the protein to cross the PVM and enter the RBC. The focus of my project is to answer crucial questions about the protein export system that include determining the in vivo function of the PTEX transporter and understanding the biochemical function of the components of the transporter complex. These experiments will improve our understanding of this parasite system and may provide new targets for anti-malarial drug development.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Victoria, Australia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
226637
Name
Kanjee Usheer
Region
Victoria
Country
Australia
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Revealing the Plasmodium falciparum virulence protein export system
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Malaria; Parasitology; Plasmepsin V (Pm-V); Plasmodium Export Element (Pexel); Plasmodium Falciparum; Plasmodium Translocon Of Exported Proteins (Ptex); Protein Folding; Protein Trafficking; Red Blood Cell Invasion; Virulence Protein Export
Abstract
This project focuses on understanding a critical process employed by the parasite Plasmodium falciparum, the causative agent of Malaria, during infection of human red blood cells. Malaria is a widespread parasitic disease that infects up to 500 million people and causes 1 million deaths a year. Drug treatments against Malaria are at risk of losing effectiveness due to increasing parasite drug resistance; thus there is an urgent need to obtain a better understanding of the biology of this organism. Malaria parasites are capable of invading and reproducing in human red blood cells (RBCs) and the parasites have developed a sophisticated system that employs hundreds of parasite virulence proteins to alter the surface features of the RBCs. These alterations, mediated by an adhesion protein, cause the infected RBCs to obstruct capillaries in several organs such as the brain, kidney and placenta leading many of the fatal clinical symptoms of the disease. In recent years a virulence protein export system has been identified that provides the mechanisms to target and transport proteins from within the parasite, across the parasitophorous vacuole membrane (PVM), into the RBC cytoplasm. Virulence proteins destined for export have a particular amino acid sequence that is recognized and cleaved by a protease named plasmepsin-V (PM-V). Following this, the cleaved protein is ferried by an unknown mechanism to a proposed molecular transporter named PTEX that may allow the protein to cross the PVM and enter the RBC. The focus of my project is to answer crucial questions about the protein export system that include determining the in vivo function of the PTEX transporter and understanding the biochemical function of the components of the transporter complex. These experiments will improve our understanding of this parasite system and may provide new targets for anti-malarial drug development.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kanjee, Usheer
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~